Bill Text: TN HB2239 | 2015-2016 | 109th General Assembly | Draft
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: As introduced, prohibits an insurance policy that provides benefits for anti-cancer medications that are injected or intravenously administered by a healthcare provider and anti-cancer medications that are patient administered from requiring a higher copayment, deductible, or coinsurance amount. - Amends TCA Title 56, Chapter 7, Part 23.
Spectrum: Slight Partisan Bill (Republican 16-9)
Status: (Introduced - Dead) 2016-03-02 - Taken off notice for cal in s/c Insurance and Banking Subcommittee of Insurance and Banking Committee [HB2239 Detail]
Download: Tennessee-2015-HB2239-Draft.pdf
Bill Title: As introduced, prohibits an insurance policy that provides benefits for anti-cancer medications that are injected or intravenously administered by a healthcare provider and anti-cancer medications that are patient administered from requiring a higher copayment, deductible, or coinsurance amount. - Amends TCA Title 56, Chapter 7, Part 23.
Spectrum: Slight Partisan Bill (Republican 16-9)
Status: (Introduced - Dead) 2016-03-02 - Taken off notice for cal in s/c Insurance and Banking Subcommittee of Insurance and Banking Committee [HB2239 Detail]
Download: Tennessee-2015-HB2239-Draft.pdf
